EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

3M Syndrome Due to Pathogenic Variant in OBSL1 Gene with Suboptimal Growth Hormone Response – A Report of Two Siblings

Eram Nahid, Madhukar Mittal, Parul Singhal, Mahendra Kumar Garg

Indian Pediatrics Case Reports · 2026-10 · 6 (4) · 211-215

DOI: 10.4103/ipcares.ipcares_344_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Pediatrics Case Reports, online erschienen am 13.11.2026. Verfasst von Eram Nahid und 3 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

3M syndrome is a rare autosomal recessive disorder characterized by severe short stature, distinctive dysmorphic features, and normal intelligence. The growth hormone (GH) axis is typically normal, with GH deficiency reported only rarely. Clinical Description: We report two siblings, a 10-year-old girl and her 7-year-old brother, born to nonconsanguineous parents, who presented with short stature and characteristic dysmorphic features of 3M syndrome. Both children had normal intelligence and were developmentally normal. Management and Outcome: Investigations revealed normal routine laboratory parameters, including anti-tissue Transglutaminase antibody, thyroid function tests, and cortisol levels. Both siblings showed typical radiological findings, including slender long bones with diaphyseal constriction and tall vertebral bodies. Endocrine evaluation revealed low peak GH responses on stimulation testing. Clinical exome sequencing identified a previously unreported pathogenic frameshift variant, c. 2100_2122del in exon 5 of the OBSL1 gene, in both siblings. Both patients were initiated on recombinant human GH therapy. After 1 year of treatment, a satisfactory growth response was observed.

Conclusion

This report describes a pathogenic OBSL1 variant associated with subnormal GH response in two siblings with 3M syndrome and a favorable short-term response to GH therapy. Early diagnosis, genetic confirmation, and appropriate endocrine management may improve growth outcomes, although long-term follow-up is required to assess sustained benefits.

Zitieren

APA

Nahid, E., Mittal, M., Singhal, P., & Garg, M. K. (2026). 3M Syndrome Due to Pathogenic Variant in OBSL1 Gene with Suboptimal Growth Hormone Response – A Report of Two Siblings. Indian Pediatrics Case Reports, 6(4), 211-215. https://doi.org/10.4103/ipcares.ipcares_344_25

Vancouver

Nahid E, Mittal M, Singhal P, Garg MK. 3M Syndrome Due to Pathogenic Variant in OBSL1 Gene with Suboptimal Growth Hormone Response – A Report of Two Siblings. Indian Pediatrics Case Reports. 2026;6(4):211-215. doi:10.4103/ipcares.ipcares_344_25

BibTeX
@article{Nahid2026,
  author = {Nahid, Eram and Mittal, Madhukar and Singhal, Parul and Garg, Mahendra Kumar},
  title = {3M Syndrome Due to Pathogenic Variant in OBSL1 Gene with Suboptimal Growth Hormone Response – A Report of Two Siblings},
  journal = {Indian Pediatrics Case Reports},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {211--215},
  doi = {10.4103/ipcares.ipcares_344_25}
}
Kostenlos starten →